what countries is retatrutide available in Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled Australia. These toxic effects may be linked to a contaminant in the Retatrutide: Can Anyone Take It

Accompanying symptoms such as nausea, vomiting, and fever strengthen this concern

Factors such as Medicaid coverage, income levels, age, and healthcare infrastructure play a crucial role in determining who can currently benefit from these medications, and addressing these disparities will be key to maximizing access to GLP-1 therapies in the years ahead

PlexusDx lists pricing up front: Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a microdose at a flat $129 per month

[7] Clinical trial participants: If retatrutide was obtained as part of a clinical trial, the trial protocol will specify a designated returns and disposal process

10.3389/fneur.2022.861843 66

doi: 10.1002/jcla.22929